Psychedelic Medicine Series: Part I

Microdose Psychedelic Insights launches Psychedelic Medicine Series
The Psychedelic Medicine Series is dedicated to bringing together practicing clinicians, researchers, and experts to explain and discuss the therapeutic use of psychedelic medicine in practice.

Microdose Psychedelic Insights (“Microdose”), a leader in B2B psychedelic intelligence, is to present a free for health workers, bi-monthly live video discussion series titled “Psychedelic Medicine Series”.

‘’We don't know what we don't know, and with psychedelics entering the mainstream, it is imperative that clinicians are brought up to speed and kept up to date to ensure the most responsible use of these medicines in clinical practice. Medical cannabis is legal in many states, but many doctors won't recommend CBD/THC because they still aren't familiar with the medicinal properties. We hope to learn from the cannabis industry and get high-quality information out to the doctors NOW so that by the time the legal framework shifts, clinicians are well informed and ready to be active participants in this emerging frontier of medicine.’’ - Julia Mirer M.D., event partner.

The first in Psychedelic Medicine Series will feature Dave Phillips Psychotherapist, Dave Phillips Counseling, Dr. Mark Braunstein Founder & CEO, Reconscious Medical, Dr. Pamela Kryskow Ketamine Assisted Therapy, Medical Lead Roots To Thrive, and Hayden Rubensohn, Physician.

Moderated by Lynn Marie Morski President of the Psychedelic Medicine Association, the panelists will cover molecules they work with in their practices, biochemistry, legal status/historical use, ongoing clinical research: for which conditions, how, predictions for future research, application in clinical practice: personal experience of practicing clinicians, current procedures/rules, benefits of therapy (and community) during preparation and integration, other beneficial modalities for after the experience.

Others Details

Time: 2:00 pm - 3:30 pm